Not enough people understand what it’s like to live with Parkinson’s. Together, we can change that.
Next has released a new exclusive range in collaboration with internationally-renowned artist Alex Echo, who was diagnosed with Parkinson’s in early 2020.
We've invested a further £490,000 to support the development of drugs to protect mitochondria and treat Parkinson's.
Results show that atomoxetine, a drug used to treat attention deficit hyperactivity disorder (ADHD), could improve thinking and impulsiveness in Parkinson’s.
Researchers in the United States have shown that a compound found in fruit - farnesol - has the potential to play a protective role to dopamine-producing brain cells.
A new bill that will change how health and care is planned and delivered in England was debated in parliament yesterday (14 July 2021)
Caroline Rassell has been appointed as our new Chief Executive. She brings 20 years of board experience in healthcare and government roles.
Broadcaster Jeremy Paxman has announced that he was recently diagnosed with Parkinson’s, and that his symptoms are currently mild.
Our Patron, The Duchess of Gloucester, and Cure Parkinson's Patron, Mike Tindall, joined a video call to talk about the need to find a cure for Parkinson's, a cause close to both their hearts.
Over 30 Scottish landmarks, including Edinburgh Castle, showed their support by lighting up in the colours of Parkinson's UK
It’s our mission to improve life for everybody affected by Parkinson’s. To stay true to this, we must proactively tackle barriers to accessing our support and NHS services, and barriers to participating in medical research.
Genna, 39, has Parkinson’s. She’s designed an exclusive range of T-shirts and bags for Next.
This new partnership will help more people understand Parkinson’s and raise vital funds to support others with the condition.
The latest report by the Royal College of Speech and Language Therapists shows the impact of lockdown on this vital therapy.
Research shows it’s possible to identify Parkinson’s based on compounds found on the surface of skin. The findings offer hope that the condition could be diagnosed through a simple swab test.
We’re investing up to £1.2m into pioneering research in partnership with the University of Sheffield, which aims to develop a drug to protect dopamine-producing brain cells.
In 2020, coronavirus (COVID-19) brought normal life to a standstill. But the Parkinson’s community showed its resilience as people found innovative ways to support each other.
New research has advanced our understanding of a protein called alpha-synuclein, which is believed to play a central role in damaging brain cells in Parkinson’s.
Scientists in the UK have uncovered evidence that simple vision tests can predict who will develop Parkinson's dementia. And the evidence shows that a loss of wiring in the brain may be the cause.